The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequential administration of trastuzumab and a CD8 T-cell-eliciting HER2/neu peptide vaccine in patients with breast cancer compared to trastuzumab alone.
A. K. Sears
No relevant relationships to disclose
G. T. Clifton
No relevant relationships to disclose
R. Patil
No relevant relationships to disclose
N. M. Shumway
No relevant relationships to disclose
M. G. Carmichael
No relevant relationships to disclose
D. C. Van Echo
No relevant relationships to disclose
J. P. Holmes
No relevant relationships to disclose
S. Ponniah
No relevant relationships to disclose
E. A. Mittendorf
No relevant relationships to disclose
G. E. Peoples
No relevant relationships to disclose